Melatonin Alters the Metabolism of the β-Amyloid Precursor Protein in the Neuroendocrine Cell Line PC12

Journal of Molecular Neuroscience

Volumn 9, Issue 2, 1997, Pages 75-92

  Song, Weihong ^a,c   Lahiri, Debomoy K ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Melatonin; Neuroblastoma cells; Pc12 cells; Pineal gland hormone; amyloid precursor protein

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; ESTRADIOL; MELATONIN; MESSENGER RNA; NERVE GROWTH FACTOR; SCAVENGER;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN; DRUG EFFECT; GENE EXPRESSION; HUMAN; IMMUNOBLOTTING; METABOLISM; MOUSE; NEUROBLASTOMA; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIOXIDANTS; BLOTTING, NORTHERN; CELL DIFFERENTIATION; ESTRADIOL; FREE RADICAL SCAVENGERS; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; MELATONIN; MICE; NERVE GROWTH FACTORS; NEUROBLASTOMA; PC12 CELLS; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031243561     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02736852     Document Type: Article

References (81)

1. Anderson J. P., Chen Y., Kim K. S., and Robakis N. K. (1992) An alternative secretase cleavage produces soluble Alzheimer amyloid precursor protein containing a potentially amyloidogenic sequence. J. Neurochem. 59, 2328-2331.
2. Arcari P., Martinelli R., and Salvatore F. (1984) The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 12, 9179-9189.
3. Arendt J. (1995) Melatonin and the Mammalian Pineal Gland. Chapman and Hill, London.
4. Arendt J. and Broadway J. (1987) Light and melatonin as Zeitgebers in man. Chronobiol. Int. 4, 273-282.
5. Axelrod J. (1974) The pineal gland: a neurochemical transducer. Science 184, 1341-1348.
6. Becker-Andre M., Wiesenberg I., Schaeren-Wiemers N., Andre E., Missbach M., Saurat J. H., and Carlberg C. (1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269, 28,531-28,534.
7. Behl C., Widmann M., Trapp T., and Holsboer F. (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
8. Benitez-King G., Huerto-Delgadillo L., and Anton-Tay F. (1991) Melatonin effects on the cytoskeletal organization of MDCK and neuroblastoma N1E-115 cells. Brain Res. 557, 289-292.
9. Birge S. J. (1996) Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J. Amer. Geriatr. Soc. 44, 865-870.
10. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
11. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., and Greengard P. (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89, 10,075-10,078.
12. Cardinali D. P. and Freire F. (1975) Melatonin effects on brain. Interaction with microtubule protein, inhibition of fast axoplasmic flow and induction of crystaloid and tubular formations in the hypothalamus. Mol. Cell. Endocrinol. 2, 317-330.
13. Checler F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.
14. Cos S., Verduga R., Fernandez-Viadero C., Megias M., and Crespo D. (1996) Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci. Letts. 216, 113-116.
15. Dell'Antone P., Bragadin M., and Zatta P. (1995) Anticholinesterase drugs: tacrine but not physostigmine, accumulates in acidic compartments of the cells. Biochim. Biophys. Acta 1270, 137-141.
16. Dori D., Casale G., Solerte S. B., Fioravanti M., Migliorati G., Cuzzoni G., and Ferrari E. (1994) Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiology 21, 121-126.
17. Dubocovich M. L. (1995) Melatonin receptors: are there multiple subtypes? Trends Pharmacol. Sci. 16, 50-56.
18. Efthimiopoulos S., Vassilacopoulou D., Ripellino J. A., Tezapsidis N., and Robakis N. K. (1996) Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells. Proc. Natl. Acad. Sci. USA 93, 8046-8050.
19. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., and Ward P. J. (1990) Cleavage of amyloid beta-peptide during constitutive processing of its precursor. Science 248, 1122-1124.
20. Estus S., Golde T. E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B. D., and Younkin S. G. (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
21. Green L. A. and Tischler A. J. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
22. Haass C., Koo E. H., Mellon A., Hung A. Y., and Selkoe D. J. (1992) Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
23. Hay R., Caputo J., Chen T. R., Macy M., McClintock P., and Reid Y. (1992) ATCC Collection Catalogue of Cell Lines and Hybridomas, 7th ed., ATCC, Rockville, MD.
24. Hilbich C., Monning U., Grund C., Masters C. L., and Beyreuther K. (1993) Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J. Biol. Chem. 268, 26,571-26,577.
25. Hinton D. R., Sadun A. A., Blanks J. C., and Miller C. A. (1986) Optic-nerve degeneration in Alzheimer's disease. New Engl. J. Med. 315, 485-487.
26. Hisama F. M. and Schllenberg G. D. (1996) Progress in molecular genetics of Alzheimer's disease. Neuroscientist 2, 3-6.
27. Iovanna J., Dusetti N., Cadenas B., and Cardinali D. P. (1990) Time-dependent effect of melatonin on actin mRNA levels and incorporation of 35S-methiom'ne into actin and proteins by the rat hypothalamus. J. Pineal Res. 9, 51-63.
28. Jaffe A. B., Toran-Allerand C. D., Greengard P., and Gandy S. E. (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269, 13,065-13,068.
29. Kim K. S., Miller D. L., Sapienze B. J., Chang C. J., Grundke-Iqbal I., Currie J. R., and Wisniewski H. M. (1988) Production and characterization of monoclonal antibodies to synthetic cerebral vascular amyloid peptide. Neurosci. Res. Commun. 2, 121-130.
30. Klein D. C. (1979) Endocrine Rhythms. Raven, New York.
31. Knepp V. M., Whatley J. L., Muchnik A., and Calderwood T. S. (1996) Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor. PDA J. Pharmaceut. Sci. Technol. 50, 163-171.
32. Knops J., Lieberburg I., and Sinha S. (1992) Evidence for a nonsecretory, acidic degradation pathway for amyloid precursor protein in 293 cells. J. Biol. Chem. 267, 16,022-16,024.
33. Kuentzel S. L., Ali S. M., Altman R. A., Greenberg B. D., and Raub T. J. (1993) The Alzheimer β-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem. J. 295, 367-378.
34. Lahiri D. K. (1994a) Effect of ionophores on the processing of the beta-amyloid precursor protein in different cell lines. Cell. Mol. Neurobiol. 14, 297-313.
35. Lahiri D. K. (1994b) Reversibility of the effect of tacrine on the secretion of the beta-amyloid precursor protein in cultured cells. Neurosci. Letts. 181, 149-152.
36. Lahiri D. K. and Farlow M. R. (1996) Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines. J. Mol. Neurosci. 7, 41-49.
37. Lahiri D. K., Nail C., and Farlow M. R. (1992) The cholinergic agonist carbachol reduces intracellular amyloid precursor protein in PC12 and C6 cells. Biochem. Int. 28, 853-860.
38. Lahiri D. K., Lewis S., and Farlow M. R. (1994) Tacrine alters the processing of beta-amyloid precursor protein in different cell lines. J. Neurosci. Res. 37, 777-787.
39. Leader D. P., Gall I., Campbell P., and Frischauf A. M. (1986) Isolation and characterization of cDNA clones from mouse skeletal muscle beta-actin mRNA. DNA 5, 235-238.
40. Lerchl A. (1994) Increased oxidation of pineal serotonin as a possible explanation for reduced melatonin synthesis in the aging Djungarian hamster (Phodopus sungorus). Neurosci. Letts. 176, 25-28.
41. Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D. A., and Markey S. P. (1980) Light suppresses melatonin secretion in humans. Science 210, 1267-1269.
42. Manev H., Uz T., Kharlamov A., and Joo J. Y. (1996) Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J. 10, 1546-1551.
43. Marushige Y., Marushige K., and Koestner A. (1992) Growth inhibition of anaplastic glioma cells by nerve growth factor. Anticancer Res. 12, 2069-2073.
44. Maurizi C. P. (1987) Dementia - the failure of hippocampal plasticity and dreams. Is there a preventative role for melatonin? Medical Hypotheses 24, 59-68.
45. Mishima K., Okawa M., Hishikawa Y., Hozumi S., Hori H., and Takahashi K. (1994) Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr. Scand. 89, 1-7.
46. Nitsch R. M., Slack B. E., Wurtman R. J., and Growdon J. H. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
47. Nitsch R. M., Farber S. A., Growdon J. H., and Wurtman R. J. (1993) Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA 90, 5191-5193.
48. Pappolla M. A., Sos M., Omar R. A., Bick R. J., Hickson-Bick D. L., Reiter R. J., Efthimiopoulos S., and Robakis N. K. (1997) Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17, 1683-1690.
49. Parsell D. A. and Lindquist S. (1993) The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Ann. Rev. Genet. 27, 437-496.
50. Pierpaoli W. and Regelson W. (1992) Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA 91, 787-791.
51. Pierpaoli W. and Regelson W. (1994) The Melatonin Miracle: Revolutionary Discoveries About the Body's Master Hormone. Simon and Schuster, New York.
52. Prinz P. N., Vitaliano P. P., Vitiello M. V., Bokan J., Raskind M., Peskind E., and Gerber C. (1982) Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type. Neurobiol. Aging 3, 361-370.
53. Rabizadeh S., Bitler C. M., Butcher L. L., and Bredesen D. E. (1994) Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc. Natl. Acad. Sci. USA 91, 10,703-10,706.
54. Refolo L., Salton S. R., Anderson J. P., Mehta P., and Robakis N. K. (1989) Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC12 cell cultures. Biochem. Biophys. Res. Commun. 164, 664-670.
55. Reiter R. J. (1995a) The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Experiment. Gerontol. 30, 199-212.
56. Reiter R. J. (1995b) Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9, 526-533.
57. Reppert S. M. and Weaver D. (1995) Melatonin madness. Cell 83, 1059-1062.
58. Reppert S. M., Weaver D. R., and Ebisawa T. (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13, 1177-1185.
59. Reppert S. M., Weaver D. R., Rivkees S. A., and Stopa E. G. (1988) Putative melatonin receptors in a human biological clock. Science 242, 78-81.
60. Richards M. L. and Sadee W. (1986) Human neuroblastoma cell lines as models of catechol uptake. Brain Res. 384, 132-137.
61. Ross R. A., Spengler B. A., and Biedler J. L. (1983) Coordinate morphological and bio-chemical interconversion of human neuroblastoma cells. J. Nat. Cancer Inst. 71, 741-747.
62. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., and Erlich H. A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491.
63. Sambamurti K., Shioi J., Anderson J. P., Pappolla M. A., and Robakis N. K. (1992) Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC 12 cells. J. Neurosci. Res. 33, 319-329.
64. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
65. Selkoe D. J. (1994) Normal and abnormal biology of the β-amyloid precursor protein. Ann. Rev. Neurosci. 17, 489-517.
66. Selkoe D. J. (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18,295-18,298.
67. Selkoe D. J. (1997) Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275, 630-631.
68. Seubert P., Oltersdorf T., Lee M. G., Barbour R., Blomquist C., Davis D. L., Bryant K., Fritz L. C., Galasko D., Thai L. J., et al. (1993) Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361, 260-263.
69. Sisodia S. S. (1992) Beta amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 89, 6075-6079.
70. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., and Price D. L. (1990) Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495.
71. Skene D. J., Vivien-Roels B., Sparks D. L., Hunsaker J. C., Pevet P., Ravid D., and Swaab D. F. (1990) Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Research. 528, 170-174.
72. Slunt H. H., Thinakaran G., Koch C. V., Lo A. C. Y., Tanzi R. E., and Sisodia S. S. (1993) Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J. Biol. Chem. 269, 2637-2644.
73. Swabb D. F., Fliers E., and Partiman T. S. (1985) The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342, 37-44.
74. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A. P., George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., and Neve R. L. (1987) Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880-884.
75. Tate B., Aboody-Guterman K. S., Morris A. M., Walcott E. C., Majocha R. E., and Marotta C. A. (1992) Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid. Proc. Natl. Acad. Sci. USA 89, 7090-7094.
76. Troy C. M. and Shelanski M. L. (1994) Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc. Natl. Acad. Sci. USA 91, 6384-6387.
77. Wallace W. C., Lieberburg I., Schenk D., Vigo-Pelfrey C., Davis K. L., and Haroutunian V. (1995) Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. J. Neurosci. 15, 4896-4905.
78. Wang A. M., Doyle M. V., and Mark D. F. (1989) Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86, 9717-9721.
79. Wiesenberg I., Missbach M., Kahlen J. P., Schrader M., and Carlberg C. (1995) Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23, 327-333.
80. Wisniewski T. and Frangione B. (1996) Molecular biology of brain aging and neurodegenerative disorders. Acta Neurobiol. Experiment. 56, 267-279.
81. Witting W., Kwa I. H., Eikelenboom P., Mirmiran M., and Swaab D. F. (1990) Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol. Psychiat. 27, 563-572.